DII may be a potential determinant of hospitalization duration among surgically treated patients with colorectal cancer

the ONA take:

The dietary inflammatory index (DII) may be used as a potential predictor of length of hospitalization among patients undergoing surgical treatment of colorectal cancer, according to a team of researchers at Jagiellonian University Medical College, in Krakow, Poland. The study sought to describe inflammatory properties of diet measured by the DII among patients surgically treated for colorectal cancer, and to identify a possible link between inflammatory properties of habitual diet and duration of hospitalization. Habitual diet was assessed using a standardized semiquantitative food frequency questionnaire completed by 689 patients. Participants’ DII was calculated using 23 dietary items; potential covariates were gender, age, marital status, lifetime physical activity, taking vitamin supplements, number of chronic diseases, cancer site, Duke’s staging and surgery type. Participants were age 58 years, with average hospitalization time of 11 days. Diet with higher anti-inflammatory properties (ie, higher DII) was negatively associated with duration of hospitalization. Multivariate logistic regression demonstrated a reduction in risk of longer stays among patients with the DII >−4.25, but only persons younger than 60 years, irrespective of Duke’s staging.

DII may be a potential determinant of hospitalization duration among surgically treated patients wit
DII may be a potential determinant of hospitalization duration among surgically treated patients wit
Inflammation is a central process responsible for health outcomes among surgical patients. Immunonutrition has been investigated as a promising modifying factor; however, inflammatory properties of habitual diet have not yet been investigated. Participants were aged 58 years, with the average hospitalization time of 11 days.
READ FULL ARTICLE From Nature
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs